The run rate required Q/Q for the next 3 quarters in a row to get to 78.5M YE rev is right at 40% per Q. That would indicate a 210% Y/Y increase from end of Q2 2024 to end of Q2 2025 assuming that run rate for one more quarter.
Suggest you might want to wait for prelim rev Q2 in early July before releasing your estimates.
You remind me a bit of that kid and his cape. Kudoos.
Ann: AVITA Medical Announces FDA Approval of RECELL GO, page-39
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.54 |
Change
-0.190(6.96%) |
Mkt cap ! $175.0M | |||
| Open | High | Low | Value | Volume |
| $2.59 | $2.61 | $2.54 | $669.4K | 259.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1235 | $2.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.55 | 15735 | 11 |
View Market Depth
| Last trade - 11.24am 05/08/2024 (20 minute delay) ? |
| AVH (ASX) Chart |